Pregnancy & lactation. FC tab: Monitor patients w/ bone marrow suppression, aplastic anemia & agranulocytosis. Cerebral hypertensive episodes may occur during the 1st wk of neurocysticercosis therapy. Patients w/ preexisting & previously undiagnosed neurocysticercosis. Pre-existing hepatic disease & elevations of hepatic enzymes. Increased risk of hepatotoxicity, & bone marrow suppression which may lead to pancytopenia, aplastic anemia, agranulocytosis & leukopenia; retinal damage & lesions in patients w/ cysterciscosis.
Susp:
Cerebral hypertensive episodes, hepatic disease, renal impairment.